+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tsumura & Co (4540) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 51 Pages
  • August 2026
  • GlobalData
  • ID: 1816483
Tsumura & Co (4540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Tsumura & Co (Tsumura) is a traditional pharmaceuticals developer that markets Kampo extract intermediates and granular Kampo formulations. The company's product portfolio comprises a range of prescription Kampo products, over-the-counter (OTC) Kampo formulations, crude drug pieces, and raw materials for crude drugs. The company's Kampo products are used to treat diseases that are difficult to treat with Western drugs, such as abdominal pain and bloating, diseases specific to women, cramps, acne, muscle spasms, lower back pain, respiratory diseases and cardiovascular diseases. The company has a business presence in the US, China, and Japan. Tsumura is headquartered in Minato-ku, Tokyo, Japan.

Tsumura & Co Key Recent Developments

  • Sep 01, 2025: Tsumura & Co announced personnel changes
  • Jun 20, 2025: Development of a Novel Breeding Method to Predict the Genetic Potential of Future Generations in Akajiso, the Raw Material for Soyo
  • May 30, 2025: Introduction of an AI Robot Platform to Automate the Weighing of Kampo Formulations
  • May 12, 2025: Tsumura & Co Announced Senior Management Changes

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Tsumura & Co - Key Facts
  • Tsumura & Co - Key Employees
  • Tsumura & Co - Key Employee Biographies
  • Tsumura & Co - Major Products and Services
  • Tsumura & Co - History
  • Tsumura & Co - Company Statement
  • Tsumura & Co - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Tsumura & Co - Business Description
  • Geographical Segment: China
  • Performance
  • Geographical Segment: Japan
  • Performance
  • Geographical Segment: Others
  • Performance
  • R&D Overview
  • Tsumura & Co - Corporate Strategy
  • Tsumura & Co - SWOT Analysis
  • SWOT Analysis - Overview
  • Tsumura & Co - Strengths
  • Tsumura & Co - Weaknesses
  • Tsumura & Co - Opportunities
  • Tsumura & Co - Threats
  • Tsumura & Co - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Tsumura & Co, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 01, 2025: Tsumura & Co announced personnel changes
  • Jun 20, 2025: Development of a Novel Breeding Method to Predict the Genetic Potential of Future Generations in Akajiso, the Raw Material for Soyo
  • May 30, 2025: Introduction of an AI Robot Platform to Automate the Weighing of Kampo Formulations
  • May 12, 2025: Tsumura & Co Announced Senior Management Changes
  • Mar 13, 2025: Certified as a Health & Productivity Management Outstanding Organization for Two Consecutive Years
  • Mar 06, 2025: Tsumura Announced Personnel Changes
  • Feb 27, 2025: Tsumura & Co Selected as an A List Company, the Highest Rating in the 2024 CDP Climate Change and Water Security Assessments
  • Feb 06, 2025: Tsumura & Co announce organizational restructuring and personnel changes
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact Us
  • Disclaimer
List of Tables
  • Tsumura & Co, Key Facts
  • Tsumura & Co, Key Employees
  • Tsumura & Co, Key Employee Biographies
  • Tsumura & Co, Major Products and Services
  • Tsumura & Co, History
  • Tsumura & Co, Other Locations
  • Tsumura & Co, Subsidiaries
  • Tsumura & Co, Key Competitors
  • Tsumura & Co, Ratios based on current share price
  • Tsumura & Co, Annual Ratios
  • Tsumura & Co, Interim Ratios
  • Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Tsumura & Co, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Tsumura & Co, Performance Chart (2022 - 2026)
  • Tsumura & Co, Ratio Charts
  • Tsumura & Co, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Tsumura & Co, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Yakult Honsha Co Ltd
  • Takara Bio Inc
  • Taisho Pharmaceutical Holdings Co Ltd
  • Sawai Group Holdings Co Ltd
  • Kracie Ltd
  • Hisamitsu Pharmaceutical Co Inc